Tsunehiko Maruyama

Tsunehiko Maruyama

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 November 2018 in European Surgical Research
Verified
Journal Article
Closed access
PDF file
SSShuji Suzuki
Shuji Suzuki
MSMitsugi Shimoda
Mitsugi Shimoda
JSJiro Shimazaki
Jiro Shimazaki
TMTsunehiko Maruyama
Tsunehiko Maruyama
YOYukio Oshiro
Yukio Oshiro
ATAkihiko Tsuchida
Akihiko Tsuchida
Background: We aimed to evaluate the use of preoperative clinicophysiological parameters as predictive risk factors for early recurrence of pancreatic ductal adenocarcinoma (PDAC) after curative resection. Methods: A total of 260 patients who underwent pancreatic resection for PDAC between 2007 and 2015 were examined retrospectively. We divided the patients into those with early recurrence (within 6 months; group A, n = 52) and those with relapse within ≥6 months or without recurrence (group B, n = 208). Data regarding clinicophysiological parameters were analyzed as predictors of disease-free survival (DFS). These factors were analyzed by χ2 tests on univariate analysis and Cox proportional hazard models on multivariate analyses. Kaplan-Meier survival curves were generated using log-rank tests. Results: Groups A and B had significantly different preoperative carbohydrate antigen 19-9 (CA19-9) levels, carcinoembryonic antigen (CEA) levels, and curability. Univariate and multivariate analysis showed that CA19-9 and CEA were independent prognostic factors for early recurrence. Patients with CA19-9 levels > 124.65 U/mL had significantly shorter DFS than those with lower levels, as did patients with CEA levels > 4.45 ng/mL. Conclusions: Our results show that elevated CA19-9 (> 124.65 U/mL) and CEA (> 4.45 ng/mL) were independent predictors of early recurrence after pancreatic resection in PDAC patients.

1 July 2021 in The American Journal of Surgery
Verified
Journal Article
Closed access
TMTsunehiko Maruyama
Tsunehiko Maruyama
MSMitsugi Shimoda
Mitsugi Shimoda
HHHiroyuki Hakoda
Hiroyuki Hakoda
ASAkihiro Sako
Akihiro Sako
KUKazumitsu Ueda
Kazumitsu Ueda
SSShuji Suzuki
Shuji Suzuki

1 June 2019 in Clinical and Experimental Gastroenterology
Verified
Journal Article
Open access
PDF file
SSShuji Suzuki
Shuji Suzuki
MSMitsugi Shimoda
Mitsugi Shimoda
JSJiro Shimazaki
Jiro Shimazaki
TMTsunehiko Maruyama
Tsunehiko Maruyama
YOYukio Oshiro
Yukio Oshiro
NHNobuhiko Harada
Nobuhiko Harada
Background: Early recurrence of distal cholangiocarcinoma (DCC) may result in a poorer prognosis. This study aimed to evaluate the clinicopathological factors that predict survival and recurrence in patients with DCC. Methods: Fifty-five patients with DCC who underwent pancreaticoduodenectomy between 2005 and 2015 were studied retrospectively. The following clinicopathological parameters were analyzed as predictors of disease-free survival (DFS) and overall survival (OS): sex, age, body mass index, presence of biliary tract decompression, macroscopic type, histological type, tumor size, TNM classification, lymph node metastasis ratio, number of positive lymph nodes (PLNs), lymphatic invasion, venous invasion, perineural invasion, proximal bile duct margin, dissected margin, portal system invasion, arterial system invasion, stage, and residual tumor. Results: Univariate analysis showed that contiguous extension of the primary tumor, PLN, lymphatic invasion, venous invasion, perineural invasion, and stage were significant prognostic factors for DFS and OS. Multivariate analysis revealed that PLN and lymphatic invasion were prognostic for DFS and OS (P<0.001). Significant differences in OS and DFS were found in analyses stratified by PLN (0, 1, 2 vs ≥3) and lymphatic invasion (0 vs 1, 2, 3). Conclusion: Among the clinicopathological parameters analyzed, PLN and lymphatic invasion were confirmed as prognostic factors for DCC.

1 April 2019 in Clinical and Experimental Gastroenterology
Verified
Journal Article
Open access
PDF file
Mitsugi ShimodaMitsugi Shimoda
Mitsugi Shimoda
TMTsunehiko Maruyama
Tsunehiko Maruyama
KNKiyotaka Nishida
Kiyotaka Nishida
KSKazuomi Suzuki
Kazuomi Suzuki
TTTomoya Tago
Tomoya Tago
SSShuji Suzuki
Shuji Suzuki
Background: Laparoscopic appendectomy (LA) has been increasingly adopted for its advantages over the open appendectomy, but there are possibilities of conversion from laparoscopic to open appendectomy (CA) if the patients had complicated appendicitis concurrently, or when the extent of inflammation prohibits successful procedure. In this retrospective study, we aimed to clarify the preoperative predictors for CA. Patients and methods: From January 2010 to April 2016, medical records of 93 consecutive patients who underwent LA for suspected appendicitis were reviewed retrospectively. Factors evaluated were age, gender, body mass index, C-reactive protein (CRP), white cell count, albumin, Neutrophil count, lymphocyte count, Neutrophil/lymphocyte ratio, preoperative CT imaging (abscess formation: yes/no, appendicolith: yes/no), operative factors (time to operation, amount of bleeding), length of hospital stay, period until oral intake after surgery, and period from initial symptoms to surgery. Results: CA occurred in nine patients (9.7%). The reason for conversion was severe dense adhesion in two cases, inadequate exposure of appendix in two cases, uncompleted appendectomy in two cases, perforated appendicitis in one case, gangrenous appendicitis in one case, and abscess formation in one case. Based on 93 patients evaluated by preoperative CT scan, significant factors in the final multivariate analysis associated with CA was CRP [odds ratio=1.13, 95% CI:1.00–1.28, p=0.04]. Conclusion: Identifying the potential factors for conversion preoperatively may assist the surgeons in making decisions concerning the management of patients with appendicitis and in the judicious use of LA.

19 December 2021 in Nutrition & Dietetics
Verified
Journal Article
Closed access
PDF file
KIKazuto Ikezawa
Kazuto Ikezawa
MHMitsuaki Hirose
Mitsuaki Hirose
TMTsunehiko Maruyama
Tsunehiko Maruyama
KYKoichiro Yuji
Koichiro Yuji
YYYoshito Yabe
Yoshito Yabe
HSHideo Suzuki
Hideo Suzuki

4 August 2020 in Nutrition and Cancer
Verified
Journal Article
Closed access
TMTsunehiko Maruyama
Tsunehiko Maruyama
MSMitsugi Shimoda
Mitsugi Shimoda
ASAkihiro Sako
Akihiro Sako
KUKazumitsu Ueda
Kazumitsu Ueda
HHHiroyuki Hakoda
Hiroyuki Hakoda
SSShuji Suzuki
Shuji Suzuki
The aim of this study was to evaluate the significance of the Glasgow prognostic score (GPS) in patients with resected gastrointestinal stromal tumors (GISTs). Forty-six GIST patients who underwent radical resection between January 2004 and December 2011 were enrolled in this retrospective study. The clinicopathological parameters examined included predictors of recurrence-free survival (RFS). Univariate and multivariate analysis of prognostic factors related to RFS were calculated using Cox proportional hazards model. The GPS classification system revealed 37 (80.4%), 6 (13.1%), and 3 (6.5%) patients with a GPS of 0, 1, and 2, respectively. Patients with GPS 1/2 had a significantly shorter RFS compared to those with GPS 0 (P = 0.01). The 3- and 5-year RFS rates for patients with GPS 0 were 94.0% and 90.9%, respectively, compared to 66.7% and 53.3%, respectively, for patients with GPS 1/2. Univariate analyses indicated that tumor size (P < 0.01), mitotic rate (P < 0.01), higher GPS (P < 0.01), and platelet count (P = 0.04) were prognostic factors for RFS; tumor size (P = 0.01) and GPS (P = 0.04) were independent prognostic factors in multivariate analysis. Preoperative high GPS were predictors of long-term prognosis in patients with resected GISTs.